Press Releases

Date	Title	PDF Version
Dec 16, 2019	Alexion Exercises Option for Two Additional GalXC™ RNAi Programs for Complement-Mediated Targets Under Collaboration With Dicerna™
Dec 06, 2019	Alexion Issues Statement on Path to Value Creation
Nov 26, 2019	Alexion to Present at the 2019 Evercore ISI HealthCONx
Nov 22, 2019	SOLIRIS® (eculizumab) Receives Approval in Japan for the Prevention of Relapse in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)
Nov 13, 2019	Alexion to Present at the 2019 Stifel Healthcare Conference
Nov 06, 2019	Alexion Announces Data Presentations at 61st American Society of Hematology Annual Meeting
Oct 23, 2019	Alexion Reports Third Quarter 2019 Results
Oct 18, 2019	Alexion Receives FDA Approval for ULTOMIRIS® (ravulizumab-cwvz) for Atypical Hemolytic Uremic Syndrome (aHUS)
Oct 16, 2019	Alexion to Acquire Achillion
Oct 10, 2019	Alexion Announces Appointment of Tanisha Carino, Ph.D., as Chief Corporate Affairs Officer

Search